_id
6918474a3c536f8df231782c
Ticker
ZLSCF
Name
ZYUS Life Sciences Corporation
Exchange
OTCGREY
Address
Unit 204, Saskatoon, SK, Canada, S7N 4L8
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.zyus.com
Description
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
Last Close
0.52
Volume
-
Current Price
0.52
Change
9.01467505241091
Last Updated
2026-01-08T13:22:24.655Z
Image
https://logo.clearbit.com/www.zyus.com
Ipo Date
-
Market Cap
41637200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
105000
Cost Of Revenue
109000
Gross Profit
-4000
Operating Expenses
3131000
Operating Income
-3026000
Interest Expense
487000
Pretax Income
-3624000
Net Income
-3624000
Eps
-0.04637327050830056
Dividends Per Share
-
Shares Outstanding
80071544
Income Tax Expense
-
EBITDA
-
Operating Margin
-2881.904761904762
Total Other Income Expense Net
35000
Cash
361000
Short Term Investments
-
Receivables
392000
Inventories
458000
Total Current Assets
1597000
Property Plant Equipment
9117000
Total Assets
10849000
Payables
-
Short Term Debt
-
Long Term Debt
6083000
Total Liabilities
23817000
Equity
-12968000
Bs_currency_symbol
CAD
Depreciation
723000
Change In Working Capital
-48000
Cash From Operations
-2521000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2332000
Net Change In Cash
-198000
Cf_currency_symbol
CAD
PE
-
PB
-3.133652285626157
ROE
27.94571252313387
ROA
-33.40400036869758
FCF
-2521000
Fcf Percent
-24.00952380952381
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
105000
Quarters > 0 > income Statement > cost Of Revenue
109000
Quarters > 0 > income Statement > gross Profit
-4000
Quarters > 0 > income Statement > operating Expenses
3131000
Quarters > 0 > income Statement > operating Income
-3026000
Quarters > 0 > income Statement > interest Expense
487000
Quarters > 0 > income Statement > pretax Income
-3624000
Quarters > 0 > income Statement > net Income
-3624000
Quarters > 0 > income Statement > eps
-0.04637327050830056
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
78148467
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-2881.904761904762
Quarters > 0 > income Statement > total Other Income Expense Net
35000
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
361000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
392000
Quarters > 0 > balance Sheet > inventories
458000
Quarters > 0 > balance Sheet > total Current Assets
1597000
Quarters > 0 > balance Sheet > property Plant Equipment
9117000
Quarters > 0 > balance Sheet > total Assets
10849000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
6083000
Quarters > 0 > balance Sheet > total Liabilities
23817000
Quarters > 0 > balance Sheet > equity
-12968000
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-3624000
Quarters > 0 > cash Flow > depreciation
723000
Quarters > 0 > cash Flow > change In Working Capital
-48000
Quarters > 0 > cash Flow > cash From Operations
-2521000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2332000
Quarters > 0 > cash Flow > net Change In Cash
-198000
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.04637327050830056
Quarters > 0 > ratios > PB
-3.133652285626157
Quarters > 0 > ratios > ROE
27.94571252313387
Quarters > 0 > ratios > ROA
-33.40400036869758
Quarters > 0 > ratios > FCF
-2521000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-24.00952380952381
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
120000
Quarters > 1 > income Statement > cost Of Revenue
51000
Quarters > 1 > income Statement > gross Profit
69000
Quarters > 1 > income Statement > operating Expenses
4086000
Quarters > 1 > income Statement > operating Income
-3966000
Quarters > 1 > income Statement > interest Expense
432000
Quarters > 1 > income Statement > pretax Income
-4424000
Quarters > 1 > income Statement > net Income
-4424000
Quarters > 1 > income Statement > eps
-0.05704166675853418
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
77557341
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-3304.9999999999995
Quarters > 1 > income Statement > total Other Income Expense Net
50000
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
559000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
339000
Quarters > 1 > balance Sheet > inventories
541000
Quarters > 1 > balance Sheet > total Current Assets
1801000
Quarters > 1 > balance Sheet > property Plant Equipment
9846000
Quarters > 1 > balance Sheet > total Assets
11782000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
5745000
Quarters > 1 > balance Sheet > total Liabilities
21566000
Quarters > 1 > balance Sheet > equity
-9784000
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-4424000
Quarters > 1 > cash Flow > depreciation
676000
Quarters > 1 > cash Flow > change In Working Capital
1173000
Quarters > 1 > cash Flow > cash From Operations
-1951000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1822000
Quarters > 1 > cash Flow > net Change In Cash
-104000
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.05704166675853418
Quarters > 1 > ratios > PB
-4.122017305805397
Quarters > 1 > ratios > ROE
45.216680294358135
Quarters > 1 > ratios > ROA
-37.54880325920896
Quarters > 1 > ratios > FCF
-1951000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-16.258333333333333
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
114000
Quarters > 2 > income Statement > cost Of Revenue
54000
Quarters > 2 > income Statement > gross Profit
60000
Quarters > 2 > income Statement > operating Expenses
3550000
Quarters > 2 > income Statement > operating Income
-3436000
Quarters > 2 > income Statement > interest Expense
432000
Quarters > 2 > income Statement > pretax Income
-3959000
Quarters > 2 > income Statement > net Income
-3959000
Quarters > 2 > income Statement > eps
-0.0532426072491901
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
74357741
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-3014.035087719298
Quarters > 2 > income Statement > total Other Income Expense Net
-7000
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
663000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
314000
Quarters > 2 > balance Sheet > inventories
573000
Quarters > 2 > balance Sheet > total Current Assets
1898000
Quarters > 2 > balance Sheet > property Plant Equipment
10440000
Quarters > 2 > balance Sheet > total Assets
12490000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
5454000
Quarters > 2 > balance Sheet > total Liabilities
19957000
Quarters > 2 > balance Sheet > equity
-7467000
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-3959000
Quarters > 2 > cash Flow > depreciation
694000
Quarters > 2 > cash Flow > change In Working Capital
-103000
Quarters > 2 > cash Flow > cash From Operations
-2831000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1592000
Quarters > 2 > cash Flow > net Change In Cash
-1239000
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.0532426072491901
Quarters > 2 > ratios > PB
-5.178254361858846
Quarters > 2 > ratios > ROE
53.01995446631847
Quarters > 2 > ratios > ROA
-31.697357886309046
Quarters > 2 > ratios > FCF
-2831000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-24.833333333333332
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
126000
Quarters > 3 > income Statement > cost Of Revenue
190000
Quarters > 3 > income Statement > gross Profit
-64000
Quarters > 3 > income Statement > operating Expenses
3329000
Quarters > 3 > income Statement > operating Income
-3203000
Quarters > 3 > income Statement > interest Expense
199000
Quarters > 3 > income Statement > pretax Income
-23774000
Quarters > 3 > income Statement > net Income
-21737000
Quarters > 3 > income Statement > eps
-0.2923300211608096
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
74357741
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-2542.063492063492
Quarters > 3 > income Statement > total Other Income Expense Net
-20289000
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
1902000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
52000
Quarters > 3 > balance Sheet > inventories
630000
Quarters > 3 > balance Sheet > total Current Assets
3362000
Quarters > 3 > balance Sheet > property Plant Equipment
11159000
Quarters > 3 > balance Sheet > total Assets
14673000
Quarters > 3 > balance Sheet > payables
4483000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
371000
Quarters > 3 > balance Sheet > total Liabilities
20017000
Quarters > 3 > balance Sheet > equity
-5344000
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-21737000
Quarters > 3 > cash Flow > depreciation
792000
Quarters > 3 > cash Flow > change In Working Capital
-2943000
Quarters > 3 > cash Flow > cash From Operations
-5300000
Quarters > 3 > cash Flow > capital Expenditures
1000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
4983000
Quarters > 3 > cash Flow > net Change In Cash
1556000
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.2923300211608096
Quarters > 3 > ratios > PB
-7.23540892964072
Quarters > 3 > ratios > ROE
406.75523952095807
Quarters > 3 > ratios > ROA
-148.14284740680162
Quarters > 3 > ratios > FCF
-5301000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-42.07142857142857
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
481000
Annuals > 0 > income Statement > cost Of Revenue
352000
Annuals > 0 > income Statement > gross Profit
129000
Annuals > 0 > income Statement > operating Expenses
15181000
Annuals > 0 > income Statement > operating Income
-14700000
Annuals > 0 > income Statement > interest Expense
755000
Annuals > 0 > income Statement > pretax Income
-35893000
Annuals > 0 > income Statement > net Income
-33805000
Annuals > 0 > income Statement > eps
-0.4546265062033017
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
74357741
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-3056.133056133056
Annuals > 0 > income Statement > total Other Income Expense Net
-20114000
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
1902000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
52000
Annuals > 0 > balance Sheet > inventories
630000
Annuals > 0 > balance Sheet > total Current Assets
3362000
Annuals > 0 > balance Sheet > property Plant Equipment
11159000
Annuals > 0 > balance Sheet > total Assets
14673000
Annuals > 0 > balance Sheet > payables
4483000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
371000
Annuals > 0 > balance Sheet > total Liabilities
20017000
Annuals > 0 > balance Sheet > equity
-5344000
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-33805000
Annuals > 0 > cash Flow > depreciation
2961000
Annuals > 0 > cash Flow > change In Working Capital
1692000
Annuals > 0 > cash Flow > cash From Operations
-9876000
Annuals > 0 > cash Flow > capital Expenditures
46000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
5972000
Annuals > 0 > cash Flow > net Change In Cash
-2076000
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.4546265062033017
Annuals > 0 > ratios > PB
-7.23540892964072
Annuals > 0 > ratios > ROE
632.5785928143713
Annuals > 0 > ratios > ROA
-230.3891501397124
Annuals > 0 > ratios > FCF
-9922000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-20.62785862785863
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
351000
Annuals > 1 > income Statement > cost Of Revenue
180000
Annuals > 1 > income Statement > gross Profit
171000
Annuals > 1 > income Statement > operating Expenses
17543000
Annuals > 1 > income Statement > operating Income
-17192000
Annuals > 1 > income Statement > interest Expense
3272000
Annuals > 1 > income Statement > pretax Income
-48439000
Annuals > 1 > income Statement > net Income
-42591000
Annuals > 1 > income Statement > eps
-0.6011653554634527
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
70847396
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-4898.005698005698
Annuals > 1 > income Statement > total Other Income Expense Net
-27402000
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
3978000
Annuals > 1 > balance Sheet > short Term Investments
1874000
Annuals > 1 > balance Sheet > receivables
161000
Annuals > 1 > balance Sheet > inventories
2042000
Annuals > 1 > balance Sheet > total Current Assets
9388000
Annuals > 1 > balance Sheet > property Plant Equipment
13894000
Annuals > 1 > balance Sheet > total Assets
41627000
Annuals > 1 > balance Sheet > payables
3435000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
637000
Annuals > 1 > balance Sheet > total Liabilities
18513000
Annuals > 1 > balance Sheet > equity
23114000
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-42591000
Annuals > 1 > cash Flow > depreciation
3106000
Annuals > 1 > cash Flow > change In Working Capital
-4750000
Annuals > 1 > cash Flow > cash From Operations
-17948000
Annuals > 1 > cash Flow > capital Expenditures
281000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
17138000
Annuals > 1 > cash Flow > net Change In Cash
3766000
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.6011653554634527
Annuals > 1 > ratios > PB
1.5938671766029249
Annuals > 1 > ratios > ROE
-184.26494765077442
Annuals > 1 > ratios > ROA
-102.31580464602301
Annuals > 1 > ratios > FCF
-18229000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-51.934472934472936
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
298000
Annuals > 2 > income Statement > cost Of Revenue
530000
Annuals > 2 > income Statement > gross Profit
-232000
Annuals > 2 > income Statement > operating Expenses
16999000
Annuals > 2 > income Statement > operating Income
-16701000
Annuals > 2 > income Statement > interest Expense
5464000
Annuals > 2 > income Statement > pretax Income
-24715000
Annuals > 2 > income Statement > net Income
-24657000
Annuals > 2 > income Statement > eps
-0.3530125202546964
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
69847381
Annuals > 2 > income Statement > income Tax Expense
-58000
Annuals > 2 > income Statement > EBITDA
-15206000
Annuals > 2 > income Statement > operating Margin
-5604.362416107382
Annuals > 2 > income Statement > total Other Income Expense Net
-2550000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
212000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
199000
Annuals > 2 > balance Sheet > inventories
4202000
Annuals > 2 > balance Sheet > total Current Assets
6266000
Annuals > 2 > balance Sheet > property Plant Equipment
17032000
Annuals > 2 > balance Sheet > total Assets
64712000
Annuals > 2 > balance Sheet > payables
8512000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
30799000
Annuals > 2 > balance Sheet > total Liabilities
59971000
Annuals > 2 > balance Sheet > equity
4741000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-24657000
Annuals > 2 > cash Flow > depreciation
3061000
Annuals > 2 > cash Flow > change In Working Capital
2619000
Annuals > 2 > cash Flow > cash From Operations
-9574000
Annuals > 2 > cash Flow > capital Expenditures
560000
Annuals > 2 > cash Flow > cash From Investing
-592000
Annuals > 2 > cash Flow > cash From Financing
9628000
Annuals > 2 > cash Flow > net Change In Cash
-538000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.3530125202546964
Annuals > 2 > ratios > PB
7.660965644378823
Annuals > 2 > ratios > ROE
-520.0801518666948
Annuals > 2 > ratios > ROA
-38.10267029299048
Annuals > 2 > ratios > FCF
-10134000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-34.006711409395976
Annuals > 2 > health Score
9
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
207000
Annuals > 3 > income Statement > cost Of Revenue
64000
Annuals > 3 > income Statement > gross Profit
143000
Annuals > 3 > income Statement > operating Expenses
22976000
Annuals > 3 > income Statement > operating Income
-22769000
Annuals > 3 > income Statement > interest Expense
2742000
Annuals > 3 > income Statement > pretax Income
-23572000
Annuals > 3 > income Statement > net Income
-23455000
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-17050000
Annuals > 3 > income Statement > operating Margin
-10999.51690821256
Annuals > 3 > income Statement > total Other Income Expense Net
1939000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
-
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-23455000
Annuals > 3 > cash Flow > depreciation
3061000
Annuals > 3 > cash Flow > change In Working Capital
2169000
Annuals > 3 > cash Flow > cash From Operations
-9574000
Annuals > 3 > cash Flow > capital Expenditures
560000
Annuals > 3 > cash Flow > cash From Investing
-592000
Annuals > 3 > cash Flow > cash From Financing
9628000
Annuals > 3 > cash Flow > net Change In Cash
-538000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-10134000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-48.95652173913044
Annuals > 3 > health Score
38
Valuation > metrics > PE
-0.04637327050830056
Valuation > metrics > PB
-3.133652285626157
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
27.94571252313387
Profitability > metrics > ROA
-226.9254852849092
Profitability > metrics > Net Margin
-34.51428571428571
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-6.213552361396304
Risk > final Score
5
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-7
Prev Risks > 1
-2
Prev Risks > 2
-34
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
40
Updated At
2026-01-20T22:51:57.668Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-29
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.05
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of ZYUS Life Sciences Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
-0.05
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.